← Back to Search

Patients under the care of TA Oncologist for Cancer

N/A
Recruiting
Led By Ana I. Tergas, MD
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Study Summary

This trial will study the feasibility, acceptability, and efficacy of an intervention to improve the doctor-patient relationship for Latino patients with advanced cancer.

Eligible Conditions
  • Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Barriers and facilitators of the therapeutic alliance
Secondary outcome measures
Perceived influence of Latino/a ethnicity on the therapeutic alliance

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Patients under the care of TA OncologistExperimental Treatment1 Intervention
These patients will be under the care of an oncologist who will be randomized to training in the TA intervention.
Group II: Patients under the care of Usual Care OncologistActive Control1 Intervention
These patients will be under the care an oncologist who will be randomized to usual care.

Find a Location

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor
565 Previous Clinical Trials
1,921,339 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,648 Previous Clinical Trials
40,931,730 Total Patients Enrolled
Columbia UniversityLead Sponsor
1,428 Previous Clinical Trials
2,460,106 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Jul 2024